Modelling Species Selectivity in Rat and Human Cytochrome P450 2D Enzymes

被引:10
|
作者
Edmund, Grace H. C. [1 ]
Lewis, David F. V. [1 ]
Howlin, Brendan J. [1 ]
机构
[1] Univ Surrey, Dept Chem, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England
来源
PLOS ONE | 2013年 / 8卷 / 05期
关键词
SECONDARY STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; CLUSTAL-W; BINDING; SERVER; MICROSOMES;
D O I
10.1371/journal.pone.0063335
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Updated models of the Rat Cytochrome P450 2D enzymes are produced based on the recent x-ray structures of the Human P450 2D6 enzyme both with and without a ligand bound. The differences in species selectivity between the epimers quinine and quinidine are rationalised using these models and the results are discussed with regard to previous studies. A close approach to the heme is not observed in this study. The x-ray structure of the enzyme with a ligand bound is shown to be a better model for explaining the observed experimental binding of quinine and quinidine. Hence models with larger closed binding sites are recommended for comparative docking studies. This is consistent with molecular recognition in Cytochrome P450 enzymes being the result of a number of non-specific interactions in a large binding site.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Isothiocyanate flavones as inhibitors of human cytochrome P450 enzymes
    Dotson, Brandan
    Lovings, La'Nese
    Liu, Jiawang
    Foroozesh, Maryam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [42] Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes
    Shimada, Tsutomu
    Takenaka, Shigeo
    Murayama, Norie
    Yamazaki, Hiroshi
    Kim, Joo-Hwan
    Kim, Donghak
    Yoshimoto, Francis K.
    Guengerich, F. Peter
    Komori, Masayuki
    CHEMICAL RESEARCH IN TOXICOLOGY, 2015, 28 (02) : 268 - 278
  • [43] Inhibition and induction of human cytochrome P450 (CYP) enzymes
    Pelkonen, O
    Mäenpää, J
    Taavitsainen, P
    Rautio, A
    Raunio, H
    XENOBIOTICA, 1998, 28 (12) : 1203 - 1253
  • [44] STEREOSELECTIVE METABOLISM OF ONDANSETRON BY HUMAN CYTOCHROME P450 ENZYMES
    Li, Qiang
    Chen, Xiaoyan
    Zhong, Dafang
    Duan, Mingyu
    DRUG METABOLISM REVIEWS, 2008, 40 : 205 - 205
  • [45] Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes
    Äbelö, A
    Andersson, TB
    Antonsson, M
    Naudot, AK
    Skånberg, I
    Weidolf, L
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (08) : 966 - 972
  • [46] The Oxidative Metabolism of Dimemorfan by Human Cytochrome P450 Enzymes
    Chou, Yueh-Ching
    Chung, Yu-Ting
    Liu, Tsung-Yun
    Wang, Szu-Yu
    Chau, Gar-Yang
    Chi, Chin-Wen
    Soucek, Pavel
    Krausz, Kristopher W.
    Gelboin, Harry V.
    Lee, Chen-Hsen
    Ueng, Yune-Fang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (02) : 1063 - 1077
  • [47] Developmental expression of cytochrome P450 enzymes in human liver
    Hakkola, J
    Tanaka, E
    Pelkonen, O
    PHARMACOLOGY & TOXICOLOGY, 1998, 82 (05): : 209 - 217
  • [48] Cytochrome P450 Enzymes as Drug Targets in Human Disease
    Guengerich, F. Peter
    DRUG METABOLISM AND DISPOSITION, 2024, 52 (06) : 493 - 497
  • [49] Bioactivation of tamoxifen by recombinant human cytochrome P450 enzymes
    Notley, LM
    de Wolf, CJF
    Wunsch, RM
    Lancaster, RG
    Gillam, EMJ
    CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (05) : 614 - 622
  • [50] In vitro stability of human recombinant cytochrome P450 enzymes
    Yang, Jiansong
    Tucker, Geoffrey T.
    Rostami-Hodjegan, Amin
    DRUG METABOLISM REVIEWS, 2006, 38 : 102 - 102